David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.45% |
| 2 | Consumer Discretionary | 10.49% |
| 3 | Communication Services | 9.04% |
| 4 | Healthcare | 8.89% |
| 5 | Financials | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
SPS Commerce
SPSC
$2.9B
| $8.62M | 0.01% |
86,824
+2,183
| +3% | +$231K |
|
|
RDUS
1352
DELISTED
Radius Health, Inc.
RDUS
| $8.61M | 0.01% |
412,629
+97,606
| +31% | +$2.06M |
|
|
ZEN
1353
CALL
DELISTED
ZENDESK INC
ZEN
| $8.57M | 0.01% |
64,600
+24,100
| +60% | +$3.45M |
|
|
MRTX
1354
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $8.56M | 0.01% |
50,000
-30,200
| -38% | -$5.98M |
|
|
CND
1355
DELISTED
Concord Acquisition Corp.
CND
| $8.56M | 0.01% |
+875,000
| New | +$8.77M |
|
1356
HUB Group
HUBG
$2.4B
| $8.54M | 0.01% |
253,886
+78,274
| +45% | +$2.35M |
|
1357
Air Products & Chemicals
APD
$67.7B
| $8.53M | 0.01% |
30,315
-348,668
| -92% | -$94.8M |
|
1358
CALL
Whirlpool
WHR
$2.65B
| $8.53M | 0.01% |
38,700
-30,300
| -44% | -$6.01M |
|
1359
Talos Energy
TALO
$2.75B
| $8.53M | 0.01% |
708,230
+200,027
| +39% | +$2.16M |
|
|
AVNS
1360
DELISTED
Avanos Medical
AVNS
| $8.51M | 0.01% |
194,560
+25,620
| +15% | +$1.2M |
|
|
FRC
1361
DELISTED
First Republic Bank
FRC
| $8.48M | 0.01% |
50,840
-100,154
| -66% | -$16.2M |
|
1362
Inovio Pharmaceuticals
INO
$133M
| $8.47M | 0.01% |
76,034
+2,292
| +3% | +$301K |
|
1363
CALL
MarketAxess Holdings
MKTX
$5.72B
| $8.46M | 0.01% |
17,000
+700
| +4% | +$373K |
|
|
MRTX
1364
PUT
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $8.46M | 0.01% |
49,400
| – | – |
|
1365
CALL
Thor Industries
THO
$4.14B
| $8.45M | 0.01% |
62,700
-1,700
| -3% | -$206K |
|
1366
Kornit Digital
KRNT
$719M
| $8.44M | 0.01% |
85,142
+5,774
| +7% | +$571K |
|
1367
Aptiv
APTV
$9.68B
| $8.41M | 0.01% |
61,018
-22,818
| -27% | -$3.32M |
|
1368
PUT
Cleveland-Cliffs
CLF
$6.57B
| $8.4M | 0.01% |
417,700
+311,100
| +292% | +$5.06M |
|
1369
Arrow Electronics
ARW
$10.3B
| $8.4M | 0.01% |
75,770
-40,779
| -35% | -$4.24M |
|
1370
PUT
Chegg
CHGG
$87.9M
| $8.39M | 0.01% |
97,900
-8,300
| -8% | -$791K |
|
1371
Lennar Class A
LEN
$21.1B
| $8.37M | 0.01% |
85,412
-141,070
| -62% | -$11.9M |
|
1372
DexCom
DXCM
$33.6B
| $8.34M | 0.01% |
92,868
+61,028
| +192% | +$5.73M |
|
1373
WPP
WPP
$5.75B
| $8.33M | 0.01% |
130,381
+44,257
| +51% | +$2.6M |
|
1374
Arbor Realty Trust
ABR
$961M
| $8.31M | 0.01% |
522,831
+369,112
| +240% | +$5.7M |
|
1375
Nektar Therapeutics
NKTR
$2.56B
| $8.3M | 0.01% |
27,661
-38,140
| -58% | -$11.9M |
|
Similar funds
David Shaw's Q1 2021 Portfolio in Review
As of Q1 2021, David Shaw held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
David Shaw withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, David Shaw opened a new position in Baidu worth $627M.
- David Shaw's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- David Shaw added most to Tesla in Q1 2021, an estimated $862M increase.
- David Shaw's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- David Shaw fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- David Shaw's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- David Shaw opened 825 new positions and closed 730 in Q1 2021.
- David Shaw's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.